These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8245416)

  • 1. Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts.
    Satoh A; Huard J; Labrecque C; Tremblay JP
    J Histochem Cytochem; 1993 Oct; 41(10):1579-82. PubMed ID: 8245416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dystrophin cytochemistry in mdx mouse muscles injected with labeled normal myoblasts.
    Chen M; Li HJ; Fang Q; Goodwin TG; Florendo JA; Law PK
    Cell Transplant; 1992; 1(1):17-22. PubMed ID: 1344288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
    Kinoshita I; Huard J; Tremblay JP
    Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDGF-receptor concentration is elevated in regenerative muscle fibers in dystrophin-deficient muscle.
    Tidball JG; Spencer MJ; St Pierre BA
    Exp Cell Res; 1992 Nov; 203(1):141-9. PubMed ID: 1426037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice.
    Mueller GM; O'Day T; Watchko JF; Ontell M
    Hum Gene Ther; 2002 Jun; 13(9):1081-90. PubMed ID: 12067441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystrophin expression in myotubes formed by the fusion of normal and dystrophic myoblasts.
    Huard J; Labrecque C; Dansereau G; Robitaille L; Tremblay JP
    Muscle Nerve; 1991 Feb; 14(2):178-82. PubMed ID: 2000106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of myoblast culture and myoblast transfer therapy in dystrophic mice].
    Jong HJ; Chen SS; Chuang YH; Chen TJ
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 Jul; 11(7):398-408. PubMed ID: 7650779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice.
    Torrente Y; D'Angelo MG; Del Bo R; DeLiso A; Casati R; Benti R; Corti S; Comi GP; Gerundini P; Anichini A; Scarlato G; Bresolin N
    Cell Transplant; 1999; 8(3):247-58. PubMed ID: 10442737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts.
    Partridge TA; Morgan JE; Coulton GR; Hoffman EP; Kunkel LM
    Nature; 1989 Jan; 337(6203):176-9. PubMed ID: 2643055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice.
    Kinoshita I; Vilquin JT; Tremblay JP
    Acta Neuropathol; 1996; 91(5):489-93. PubMed ID: 8740229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.
    Benabdallah BF; Bouchentouf M; Tremblay JP
    Transplantation; 2005 Jun; 79(12):1696-702. PubMed ID: 15973171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Muscle regeneration in mdx mouse, and a trial of normal myoblast transfer into regenerating dystrophic muscle].
    Takemitsu M; Arahata K; Nonaka I
    Rinsho Shinkeigaku; 1990 Oct; 30(10):1066-72. PubMed ID: 2279357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
    Qu Z; Huard J
    Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new technique to identify hybrid myotubes in vitro without culture fixation.
    Labrecque C; Huard J; Dansereau G; Robitaille L; Tremblay JP
    J Histochem Cytochem; 1991 Jan; 39(1):139-43. PubMed ID: 1701185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of dystrophin and neurofilament protein in muscle spindles of normal and Mdx-dystrophic mice: an immunocytochemical study.
    Nahirney PC; Ovalle WK
    Anat Rec; 1993 Apr; 235(4):501-10. PubMed ID: 8465985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin expression following the transplantation of normal muscle precursor cells protects mdx muscle from contraction-induced damage.
    Rousseau J; Dumont N; Lebel C; Quenneville SP; Côté CH; Frenette J; Tremblay JP
    Cell Transplant; 2010; 19(5):589-96. PubMed ID: 20650035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.
    Huard J; Verreault S; Roy R; Tremblay M; Tremblay JP
    J Clin Invest; 1994 Feb; 93(2):586-99. PubMed ID: 8113396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic reversion/suppression of the mouse mdx phenotype in vivo.
    Hoffman EP; Morgan JE; Watkins SC; Partridge TA
    J Neurol Sci; 1990 Oct; 99(1):9-25. PubMed ID: 2250176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells.
    Hodgetts SI; Beilharz MW; Scalzo AA; Grounds MD
    Cell Transplant; 2000; 9(4):489-502. PubMed ID: 11038066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.